[361]
Colon Cancer Screening Friday,May 5,2006,11 am- 12 pmEDT Medical ...
[39,2 KB]
From [doh.state.fl.us] Last viewed: 25.06.2006
Key Objectives
Following participation in this activity,participants
should be able to:
1. discuss new evidence-based diagnostic
methods in the field of gastroenterology;
2. describe new technologies,devices,and
strategies of treatment;
3. apply recent clinical research findings to
practice.
Accreditation and Sponsorship
This continuing medical education activity has
been planned and implemented in accordance with
the Essential Areas and Policies of the Accreditation
Council for Continuing Medical Education (ACCME)
through the joint sponsorship of Medical Education
Solutions Group (MESG) and the Duke Clinical
Research Institute. MESG is accredited by the ACCME
to provide continuing medical education for
physicians.
Colon Cancer Screening
Friday,May 5,2006,11 a.m.- 12 p.m.EDT
Robert Sandler,MD,MPH
Professor of Medicine,Gastroenterology and ...
[362]
Revealing New Clues About the Spread of Colon Cancer
[246,4 KB]
From [www.hhmi.org] Last viewed: 25.06.2006
Introduction
Clinical and basic science research programs within the Michael E. DeBakey
Department of Surgery continue to raise the standards each year. The success of the individual
programs is recognizable through the increases in research funding, publications in quality
journals and the international reputation of the department. In order to recognize the
accomplishments of these principle investigators, plan our future missions and encourage young
investigators, we are presenting the "2005 Molecular Surgeon Research Day," on December 16,
2005.
During today’s event, all faculty, surgical residents/fellows, postdoctoral fellows,
associates, students and other research staff in the department are invited and encouraged to
attend. During the event, our visions, current status and future plans for our research programs
will be discussed. Ten principal investigators will receive the "2005 Molecular Surgeon ...
[363]
Nebraska Colon Cancer Screening Program Recruitment and ...
[23,1 KB]
From [www.hhs.state.ne.us] Last viewed: 25.06.2006
Nebraska Colon Cancer Screening Program Recruitment and
Distribution Algorithm
Client received EWM
enrollment in Clinician’s office,
completes the form and sends it
to Central Office
Client calls Central Office,
receives EWM enrollment by
mail, enrollment completed
and returned to EWM Central
Office
Client completes Presumptive
Enrollment in Clinic; enroll-
ment sent to EWM Central
Client enrolls in EWM with
Outreach; enrollment sent to
Central Office
NCP enroll-
ment and
health history
sent to client
along with let-
ter confirming
EWM
enrollment
NCP enrollment
and health his-
tory for anyone
over 50 years in
the same house-
hold included
Health
History Assess-
ment
Referral /
Educational
Materials
Colonoscopy
or FOBT
Client re-
ceives NCP
...
[364]
Colon Cancer Guideline.indd
[66,9 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
[365]
Colon Cancer Guideline.indd
[144,5 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
Tobacco Cessation Guideline
These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation
and treatment of patients. They are not intended to replace a clinician’s judgment or to establish a protocol for all
patients with a particular condition. A guideline will rarely establish the only approach to a problem.
GUIDELINE HISTORY and APPROVAL
ACTION
SEED GUIDELINE and/or MAIN
INFORMATION & GROUP SOURCE(S)
DATE
ORGANIZATION
Guideline reviewed
and approved
Treating Tobacco Use and dependence Clinical
practice Guideline. U.S. Department of Health
and Human Services. June 2000
Website located at:
www.surgeongeneral.gov/tobacco/
Sept. 13, 2004
Geisinger Health Plan/
Tobacco Cessation Clinical
Guideline Team
Guideline reviewed
and approved
Same as above
Sept. 30, ...
[366]
Colon Cancer Guideline.indd
[219,1 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
Geisinger Health Plan Clinical Guidelines
www.thehealthplan.com
Page
1
Chronic Obstructive Pulmonary Disease
(COPD) Clinical Guideline
These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and
treatment of patients. They are not intended to replace a clinician’s judgment or to establish a protocol for all patients
with a particular condition. A guideline will rarely establish the only approach to a problem.
GUIDELINE HISTORY and APPROVAL
ACTION
SEED GUIDELINE and/or MAIN
INFORMATION & GROUP SOURCE(S)
DATE
ORGANIZATION
Guideline reviewed,
revised and
approved
American Thoracic Society. Statement: Standards
for the diagnosis and care of patients with chronic
obstructive pulmonary disease. Am J Respir Crit
Care Med 1995;152(5, pt 2):S77-S121.
...
[367]
Colon Cancer Guideline.indd
[136,7 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
[368]
Colon Cancer Guideline.indd
[459,3 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
Geisinger Health Plan Clinical Guidelines
www.thehealthplan.com
Page
1
Hypertension Clinical Guideline
These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation
and treatment of patients. They are not intended to replace a clinician’s judgment or to establish a protocol for all
patients with a particular condition. A guideline will rarely establish the only approach to a problem.
GUIDELINE HISTORY and APPROVAL
ACTION
SEED GUIDELINE and/or MAIN
INFORMATION & GROUP
SOURCE(S)
DATE
ORGANIZATION
Guideline Reviewed,
Revised and
Approved
Sixth Report of the Joint National
Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure (JNC IV) per National Institute of
Health
July 5, 2001
Geisinger Health Plan/
Clinical ...
[369]
Colon Cancer Guideline.indd
[127,6 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
Geisinger Health Plan Clinical Guidelines
www.thehealthplan.com
Page 1
Acute Low Back Pain Guideline
These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation
and treatment of patients. They are not intended to replace a clinician’s judgment or to establish a protocol for all
patients with a particular condition. A guideline will rarely establish the only approach to a problem.
GUIDELINE HISTORY and APPROVAL
ACTION
SEED GUIDELINE and/or MAIN
INFORMATION & GROUP SOURCE(S)
DATE
ORGANIZATION
Guideline reviewed
and approved
1.Institute for Clinical Systems Integration (ICSI)
Acute Low Back Pain Guideline (Dec 2000
version)
2. Acute Low Back Pain Guideline in Adults.
Clinical practice guideline, No. 14. Rockville,
MD: U.S. Dept. of Health and Human Services,
...
[370]
Colon Cancer Guideline.indd
[108,4 KB]
From [www.thehealthplan.com] Last viewed: 25.06.2006
[371]
Telomeric Recombination in Mismatch Repair Deficient Human Colon ...
[513,9 KB]
From [www4.utsouthwestern.edu] Last viewed: 25.06.2006
[ CANCER RESEARCH 64, 3444–3451, May 15, 2004]
Telomeric Recombination in Mismatch Repair Deficient Human Colon Cancer Cells
after Telomerase Inhibition
Oliver E. Bechter,
1
Ying Zou,
2
William Walker,
2
Woodring E. Wright,
2
and Jerry W. Shay
2
1
University of Innsbruck, Department of Internal Medicine, Innsbruck, Austria and
2
University of Texas Southwestern Medical Center, Department of Cell Biology, Dallas, Texas
ABSTRACT
The majority of human malignancies use telomerase to maintain te-
lomere homeostasis. Antitelomerase therapy is therefore a promising
approach for a cancer -specific therapy. The alternative lengthening of
telomeres pathway (ALT) is a recombination-based, telomerase-independ-
ent mechanism of telomere length control. It is widely ...
[372]
Na monocarboxylate transport (SMCT) protein expression correlates ...
[1514,6 KB]
From [www.csupomona.edu] Last viewed: 25.06.2006
Na monocarboxylate transport (SMCT) protein
expression correlates with survival in colon cancer :
Molecular characterization of SMCT
Viktoriya Paroder*, Shelly R. Spencer
†
, Monika Paroder*, Diego Arango
‡
, Simo Schwartz, Jr.
‡
, John M. Mariadason
§
,
Leonard H. Augenlicht
§
, Sepehr Eskandari
†
, and Nancy Carrasco*
¶
*Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461;
†
Biological Sciences Department, California State
Polytechnic University, Pomona, CA 91768;
‡
Molecular Oncology and Aging Group, Molecular Biology and Biochemistry Research Center, Valle Hebron
Hospital Research Institute, Passeig Valle d’Hebron 119-129, 08035 Barcelona, Spain; and
§
Department of Oncology, Montefiore ...
[373]
40-42 Colon Cancer
[4022,6 KB]
From [www.overlookview.com] Last viewed: 25.06.2006
OVERLOOK VIEW 3.06
WWW.OVERLOOKVIEW.COM
People with inflammatory bowel disease,
which causes inflammation of the colon , have a
higher risk as well.
Other risk factors include being very over-
weight and inactive. “Everyone who can
should exercise,” says Dr. Levinson. “There’s
no question that inactivity as well as obesity
are factors for colorectal disease.”
Heavy use of alcohol and cigarette smoking
are both associated with higher rates of colorec-
tal cancer .According to the American Cancer
Society, recent studies show that smokers are
30 to 40 percent more likely than non-smokers
to die of the disease.
Role of diet debated
The role of diet in the prevention of col-
orectal cancer is somewhat unclear. A recent
large federal study of postmenopausal
women found that those assigned to a low-fat
diet had the same rates of cancer , including
colorectal ...
[374]
March is Colon Cancer Awareness Month
[34,3 KB]
From [www.dukescounty.org] Last viewed: 25.06.2006
colon
cancer
1146
March is Colon Cancer Awareness Month
Early Detection Can Mean A Cure
When Katie Couric broadcast her own colonoscopy live on the Today Show back in March of 2000, she made Americans aware that early detection of colon cancer can mean a cure. After the broadcast, an initial wave of excitement followed and many people received their first colonoscopy. Without ongoing celebrity endorsement, patient interest in colonoscopy has waned somewhat. Only a third of the people who should be screened for colon cancer get simple tests that can identify colon cancer in its curable stages.
Third Leading Cause of Cancer in the U.S.
Colon cancer strikes more than 120,000 Americans every year and accounts for 55,000 deaths. It is the third leading cancer in both men (after lung and prostate cancer ) and women (after lung and breast ...
[375]
COLON CANCER
[203,2 KB]
From [www.dhsspsni.gov.uk] Last viewed: 25.06.2006
REVISED 7 JUNE 2004
DIRECTORY OF
COLON CANCER
SPECIALIST TEAMS
EASTERN HEALTH AND SOCIAL SERVICES BOARD
COLON
CANCER UNIT
based at
BELFAST CITY HOSPITAL & ROYAL GROUP OF HOSPITALS
unless otherwise stated
Belfast City Hospital - Telephone 028 90 263810
Royal Group of Hospitals - Telephone 028 90 240503
STATUS
NAME
BASE HOSPITAL
Lead Clinician
Mr R J Maxwell
RHT
Specialist Surgeon
Mr K Gardiner
Mr S T Irwin
Mr K Khosraviani
Mr V Loughlin
Mr A Kennedy
Mr D Carey
RHT
RHT
RHT
BCH/LVH
BCH/LVH
BCH
Gastroenterologist
Dr JSA Collins
Dr RGP Watson
Dr B Johnston
Dr S Johnston
RHT
RHT
RHT
BCH
Chemotherapy Nurse
As per Oncology
BCH
Radiologist (Lead)
Dr B Kelly
...
[376]
HUMAN COLON CANCER TISSUE ARRAY
[193,0 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-074
Each dot represents a DISEASED tissue spot from one individual specimen that was selected and
pathologically confirmed
Cases: 80
Cores: 80
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: Anti-cytokeratin (CK)
antibody confirmed
Layout : 8 x 10
1
2
3
4
5
6
7
8
9
10
A
1
2
3
4
5
6
7
8
9
10
B
11
12
13
14
15
16
17
18
19
20
C
21
22
23
24
25
26
27
28
29
30
D
31
32
33
34
35
36
...
[377]
HUMAN COLON CANCER TISSUE ARRAY
[182,7 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-068
Each three (3) dots from three different tissue spots represents one single specimen that was pathologically
selected and confirmed (Rectum adenocarcinoma tissue array)
Cases: 21
Cores: 63
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: L-CK confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
35
...
[378]
HUMAN COLON CANCER TISSUE ARRAY
[184,4 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-067
Each three (3) dots from three different tissue spots represents one single specimen that was selected and
pathologically confirmed (Rectum adenocarcinoma tissue array)
Cases: 21
Cores: 63
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: L-CK confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
35
...
[379]
Physician Barriers to Colon Cancer Screening
[36,4 KB]
From [www5.doh.wa.gov] Last viewed: 25.06.2006
1
Physician Barriers to Colon Cancer Screening
Several studies have demonstrated that physician recommendation is a powerful predictor of
colon cancer screening.
1-3
In Washington State, having discussed colon cancer screening with a
physician significantly increased the odds of being up-to-date for colon cancer screening.
4
Despite the power of physician recommendations, colon cancer screening rates are low.
Physicians and other healthcare providers face multiple barriers to colon cancer screening. In
this report, we discuss recent literature concerning these barriers, including physician knowledge,
practice characteristics, and patient factors.
Physician Knowledge
A recent survey of internal medicine residents, internal medicine attendings, and medical
students revealed that knowledge of American Cancer Society (ACS) colon cancer screening
...
[380]
Assay Validation for Identification of Hereditary Nonpolyposis ...
[592,5 KB]
From [www.mcrs.dk] Last viewed: 25.06.2006
Assay Validation for Identification of Hereditary
Nonpolyposis Colon Cancer -Causing Mutations in
Mismatch Repair Genes MLH1 , MSH2 , and MSH6
Madhuri Hegde,* Maria Blazo,* Belinda Chong,*
Tom Prior,
†
and Carolyn Richards*
From The Diagnostic Sequencing Laboratory, * Department of
Molecular and Human Genetics, Baylor College of Medicine,
Houston, Texas; and the Ohio State University,
†
Department of
Pathology, Columbus, Ohio
Hereditary nonpolyposis colon cancer (HNPCC, On-
line Mendelian Inheritance in Man (OMIM) 114500) is
an autosomal dominant disorder that is genetically
heterogeneous because of underlying mutations in
mismatch repair genes, primarily MLH1 , MSH2 , and
MSH6 . One challenge to correctly diagnosing HNPCC
is that the large size of the causative genes makes
identification of mutations both labor ...
[381]
HUMAN COLON CANCER TISSUE ARRAY
[35,3 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
[382]
HUMAN COLON CANCER TISSUE ARRAY
[35,6 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-059
Each three (3) dots from three different tissue spots represents one single specimen that was selected and
pathologically confirmed ( Colon Adenocarcinoma tissue array)
Cases: 23
Cores: 63
Diameter: 1.5mm
Thickness: 5 m
Standard IHC: L-CK confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33 ...
[383]
HUMAN COLON CANCER TISSUE ARRAY
[36,9 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-051
Each dot represents a DISEASED tissue spot from one individual specimen that was selected and
pathologically confirmed ( colon carcinoma tissue array)
Cases: 70
Cores: 72
Diameter: 1.5mm
Thickness: 5 m
Standard IHC: L-CK confirmed
Layout : 8 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
35
...
[384]
HUMAN COLON CANCER TISSUE ARRAY
[37,3 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-050
Each dot represents a DISEASED tissue spot from one individual specimen that was selected and
pathologically confirmed ( colon carcinoma tissue array)
Cases: 70
Cores: 72
Diameter: 1.5mm
Thickness: 5 m
Standard IHC: CEA confirmed
Layout : 8 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
35
...
[385]
HUMAN COLON CANCER TISSUE ARRAY
[35,0 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-066
Each three (3) dots from three different tissue spots represents one single specimen that was selected and
pathologically confirmed (Rectum adenocarcinoma tissue array)
Cases: 21
Cores: 63
Diameter: 1.5mm
Thickness: 5 m
Standard IHC: L-CK confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
...
[386]
HUMAN COLON CANCER TISSUE ARRAY
[37,0 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN COLON CANCER TISSUE ARRAY
Catalog Number:
TMA-065
Each three (3) dots from three different tissue spots represents one single specimen selected and
pathologically confirmed (Rectum adenocarcinoma tissue array)
Cases: 22
Cores: 72
Diameter: 1.5mm
Thickness: 5 m
Standard IHC: CEA confirmed
Layout : 8 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
...
[387]
HUMAN COLON CANCER TISSUE ARRAY
[36,7 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
[388]
Colon Cancer Expert: Comment on New Virtual Colonoscopy Study
[21,5 KB]
From [www.microsystem.re.kr] Last viewed: 25.06.2006
Source: American College of Gastroenterology
(ACG)
Released: Wed 14-Apr-2004, 08:00
ET
Colon Cancer Expert: Comment on New
Virtual Colonoscopy Study
Libraries
Medical News
Keywords
COLORECTAL CANCER , COLONOSCOPY, CT COLONOGRAPHY
Contact Information
Available for logged-in reporters only
DescriptionExpert on colonoscopy and colorectal cancer screening Douglas K. Rex, M.D.,
President of the ACG and a co-author of today's new study in JAMA on CT colonography
is available to discuss findings.
Newswise — Findings of a new multicenter study by Cotton et al. published today in the
Journal of the American Medical Association comparing standard colonoscopy with CT
colonography for the detection of colorectal cancer reveal that this technology, in the
form used most often in the United States, while of significant interest, is not presently a
viable option ...
[389]
Metastasis of colon cancer cells reversed in vitro.doc
[76,7 KB]
From [www.microsystem.re.kr] Last viewed: 25.06.2006
Metastasis of colon cancer cells reversed in vitro
P
UBLIC RELEASE DATE
: 5-J
AN
-2004
Contact: Alex Smith
Alex_smith@margeotes.com
212-460-0563
Weizmann Institute
Weizmann Institute scientists have succeeded in reversing the metastatic properties
of colon cancer cells, in vitro. The findings, published in the Nov. 24 issue of The
Journal of Cell Biology, uncover a key process involved in the metastasis of colon
cancer cells and raise hopes that target-specific drugs might be devised to prevent, or
reverse, the invasive behavior of metastatic colon cancer cells. Colon cancer is the
second most prevalent type of cancer in men and third in women in the Western world.
The researchers, headed by Prof. Avri Ben-Ze'ev of the Molecular Cell Biology
Department, have confirmed that the invasive behavior of colon cancer ...
[390]
CA EXTRACT INDUCES CELL CYCLE ARREST IN CACO-2 HUMAN COLON CANCER ...
[296,8 KB]
From [www.med.cmu.ac.th] Last viewed: 25.06.2006
Chiang Mai Med Bull 2005;44(1):21-28.
Original article
C
ENTELLA
A
SIATICA
EXTRACT INDUCES CELL CYCLE
ARREST IN CACO-2 HUMAN COLON CANCER CELLS
Piyawan Bunpo,
1,2
B.Sc., Keiko Kataoka,
2
Ph.D., Hideki Arimochi,
2
Ph.D.,
Haruyuki Nakayama,
2
M.Sc., Tomomi Kuwahara,
2
Ph.D.,
Yoshinari Ohnishi,
2
Ph.D., Usanee Vinitketkumnuen,
1
Ph.D.
1
Department of Biochemistry, Faculty of Medicine, Chiang Mai University,
Chiang Mai, Thailand,
2
Department of Molecular Bacteriology, Graduate School of
Medicine, The University of Tokushima, Tokushima, Japan 770-8503
Abstract Centella asiatica is traditionally a medicinal plant frequently employed in the
practice ...